Study%20Results%20-%20ClinicalTrials%20NCT00376168.pdf (166.92 kB)

Study Results - ClinicalTrials NCT00376168

Download (166.92 kB)
journal contribution
posted on 28.03.2018 by Einat Brill Almon
Results from Study PB-06-001, ‘A Phase III Multicenter, Randomized, Double-Blind Trial to Assess the Safety and Efficacy of Two Parallel Dose Groups of Plant Cell Expressed Recombinant Human Glucocerebrosidase (prGCD) in Patients with Gaucher Disease’. ERT-naïve adult patients (N=32) with a total treatment duration of 9 months (study started on August 2007 and ended September 2009). Results available at ClinicalTrials.gov: NCT00376168. Please acknowledge the National Library of Medicine (NLM) in subsequent use of this document. While using these results please cite the study in PLOS One and acknowledge the National Library of Medicine.

History

dc.format.extent

170927

dc.identifier.uri

http://hdl.handle.net/10255/dryad.160657

Licence

Exports